| abstract |
The present invention relates to the field of pneumococcal capsular saccharide conjugate vaccines. In particular, there is provided a multivalent Streptococcus pneumoniae immunoconjugate composition comprising a variety of conjugated capsular saccharides from a variety of S. pneumoniae serotypes conjugated to two or more different carrier proteins, such compositions comprising diphtheria toxoid ( DT) or CRM197, optionally 19F is the only saccharide in the composition conjugated to diphtheria toxoid (DT) or CRM197. |